Extended Data Table 2 Geometric mean (mean, %CV) budigalimab pharmacokinetic parameters following Q4W administration in stage I

From: Budigalimab, an anti-PD-1 inhibitor, for people living with HIV-1: a randomized, placebo-controlled phase 1b study